Skip to Main Content

Paper Details

New advances in DPYD genotype and risk of severe toxicity under capecitabine.
PLoS ONE
69
2017
3'UTR, 5'UTR, D342G, D949V, DPD, DPD-deficiency, DPYD, DPYD exome, DPYD genotype, DPYD variants, Deficiency in dihydropyrimidine dehydrogenase (, F100L, I560S, R592W, SNPs, UH2, advanced breast cancer, capecitabine, coding regions, dihydropyrimidine, dihydropyrimidine dehydrogenase, dihydrouracil, fluoropyrimidine, intronic regions, patient, patients, uracil, variants
Author NameAffiliation
David SalgadoAix-Marseille University, INSERM UMR S
  • 1 - 1

Datasets

Release 1.2